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Pericytes are modified smooth muscle cells that closely enwrap small blood vessels, regulating and 
supporting the microvasculature through direct endothelial contact. Pericytes demonstrate a distinct 
immunohistochemical profile, including expression of αSMA (Smooth Muscle Actin), CD146, PDGFRβ (Platelet 
Derived Growth Factor Receptor β), and RGS5 (regulator of G-protein signaling 5). Previously, pericyte related 
antigens have been observed to be present among a group of soft tissue tumors with a perivascular growth pattern, 
including glomus tumor, myopericytoma and angioleiomyoma. Similarly, malignant tumor cells have been shown to 
pericyte-like immunoprofile when present in a perivascular location, seen in malignant melanoma, glioblastoma, and 
adenocarcinoma. Here, we examine well-differentiated liposarcoma specimens, which showed some element of 
perivascular areas with the appearance of smooth muscle (N=7 tumors). Immunohistochemical staining was 
performed for pericyte antigens, including αSMA, CD146, PDGFRβ, and RGS5. Results showed consistent 
pericytic marker expression among liposarcoma tumor cells within a perivascular distribution. MDM2 
immunohistochemistry and fluorescence in situ hybridization for MDM2 revealed that these perivascular cells were 
of tumor origin (7/7 tumors), while double immunohistochemical detection for CD31/CD146 ruled out an 
endothelial cell contribution. These findings further support the concept of pericytic mimicry, already established in 
diverse malignancies, and its presence in well-differentiated liposarcoma. The extent to which pericytic mimicry has 
prognostic significance in liposarcoma is as yet unknown. 
 




















Pericytes are modified smooth muscle cells that closely enwrap small blood vessels, regulating and 
supporting the microvasculature through direct endothelial contact.  Pericytes demonstrate a distinct 
immunohistochemical profile, including expression of αSMA (Smooth Muscle Actin), CD146, PDGFRβ (Platelet 
Derived Growth Factor Receptor β), and RGS5 (regulator of G-protein signaling 5), without evidence of endothelial 
differentiation 
1, 2
. Current interests in pericytes stem in large part from the growing understanding that this cell type 
represents a native mesenchymal stem cell (MSC) progenitor cell 
1, 3-9
. Indeed, purified pericytes give rise to 
multiple mesodermal tissues after in vitro differentiation or in vivo transplantation, including bone, adipose, 
cartilage, and muscle – features identical to traditionally derived bone marrow MSC 
9, 10
.  
Growing data suggests that when tumor cells adopt a perivascular location, they also adopt cell surface 
markers characteristic of pericytes. This phenomenon is best understood in malignant melanoma, where tumor cells 
adopt a perivascular migration pattern, or ‘angiotropism’ 
11-13
. This perivascular invasion, also called extravascular 
migratory metastasis (EVMM), is an under recognized route of tumor spread, and associated with a poor prognosis 
in melanoma 
13
. Similarly, in the malignant brain tumor glioblastoma, tumor cells adopt a pericyte-like location 
associated with perivascular invasion 
14, 15
. In fact, using cell-tracking techniques, investigators have found that the 
majority of vessel-lining pericyte-like cells in glioblastoma are actually of tumor cell origin. Likewise, recent 
research suggests that pancreatic and prostatic adenocarcinoma exhibit perivascular invasion for regional spread, 
although this has been less well studied 
16, 17
. In summary, pericyte marker expression, also termed ‘pericyte 
mimicry’ is a characteristic finding across all studied tumors with a perivascular tumor growth. 
A subset of liposarcomas display heterologous differentiation, including smooth muscle, bone, and 
cartilage. Non-neoplastic adipose tissue is a rich source of pericytes 
18-22
, and it is currently assumed that tissue 
resident MSC are the precursors for these heterologous components within liposarcoma. Of particular interest are 
areas with the appearance of smooth muscle within well-differentiated liposarcoma 
23-26
. Areas resembling smooth 
muscle often appear to arise from and radiate outwards from intratumoral blood vessels, usually in a multifocal 
fashion 
23
. These perivascular proliferations house atypical stromal cells characteristic of liposarcoma, often within 
the vessel wall. Of note, these perivascular cells demonstrate immunoreactivity Smooth Muscle Actin (SMA)
23
, but 


















Here, we examine well-differentiated liposarcoma specimens. We hypothesized that these perivascular 
areas with the appearance of smooth muscle would be associated with a pericyte immunophenotype, or ‘pericytic 
mimicry,’ within liposarcoma tumor cells. 
 
2. Materials and Methods 
2.1 Tissue Identification and Histology  
Tumors were identified using a retrospective review of the pathology slide archives of the Department of Pathology 
and Laboratory Medicine at the University of California, Los Angeles (UCLA), examining 55 cases with a diagnosis 
of ‘well-differentiated liposarcoma’ or ‘atypical lipomatous tumor.’ Slides were reviewed by two independent 
pathologists to ensure accuracy of diagnosis, and to identify tumors with some element of perivascular areas with 
the appearance of smooth muscle (S.M.D and A.W.J). Cases with dedifferentiation or greater than 5 mitotic figures 
per 10 HPF were not included. Patient information was obtained, including age, sex, tumor location, tumor size, and 
previous cytogenetic studies performed during the initial diagnostic evaluation. Formalin fixed paraffin embedded 
(FFPE) tumor tissue from patients were acquired from the tissue archives, under UCLA IRB approval # 13-000918.  
 
2.2 Immunohistochemistry 
Immunohistochemistry for pericyte markers was performed using the ABC method (Vectastain Elite ABC, 
Vector Laboratories, Burlingame, CA, USA) using DAB as the chromogen (ImmPACT DAB, Vector Laboratories). 
Multiple antigens were detected by multiplexing the ABC method and DAB chromogen with an alkaline 
phosphatase polymer detection method (ImmPress-AP Polymer Detection, Anti-mouse IG, Vector Laboratories) and 
Vector Red® chromogen (Vector Red® Alkaline Phosphatase Substrate, Vector Laboratories).  
The following primary antibodies were used: monoclonal mouse anti-MDM2 (1/100, EMD Millipore), 
monoclonal mouse anti-αSMA (1/75, [1A4], ABCAM), monoclonal rabbit anti-CD146 (1/500, EPR3208, ABCAM, 
Cambridge, MA, USA), monoclonal rabbit anti-PDGFRβ (1/100, [2E8E1], monoclonal mouse anti-RGS5 (1/100, 
[89C2], Cell Signaling Technologies), and monoclonal mouse anti-CD31 (1/100, [89C2], Cell Signaling 
Technologies). The following secondary antibodies were used: polyclonal goat biotinylated anti-rabbit IgG (1/500, 
Sigma, St. Louis, MO, USA), polyclonal horse anti-mouse IgG (1/500,[H + L], Vector Laboratories), polyclonal 


















 Heat mediated antigen retrieval was performed for all immunohistochemical stains in 1 mM tris-EDTA, 
0.01% Tween-20 (Sigma), pH 8. Non-specific antibody binding was blocked (IHC-TEK Antibody Diluent, pH 7.4, 
IHC World, LLC, Woodstock, MD, USA). Endogenous peroxidase and alkaline phosphatase blocking solution was 
used (BLOXALL Endogenous Peroxidase and Alkaline Phosphatase Blocking Solution, Vector Laboratories). 
Mayer’s hematoxylin was used as a nuclear counterstain (1/5, ABCAM) and slides were mounted using an aqueous 
media (VectaMount AQ, Vector Laboratories). In all cases, immunohistochemical staining without primary antibody 
was used as a negative control. 
 
2.3 Fluorescence in situ hybridization (FISH) 
 Fluorescence in situ hybridization (FISH) was performed using commercially available fluorescently 
labeled dual-color MDM2 (red)/CEP 12 (green) probe sets from Abbott-Molecular, IL, USA. The FISH 
hybridization and analyses were performed on 2 μm thick formalin fixed paraffin tissue sections, following the 
manufacturer’s suggested protocols. The cells were counterstained with DAPI (4',6-diamidino-2-phenylindole) and 
the red and green fluorescent probe signals were simultaneously observed and imaged under a Zeiss (Axiophot) 
Fluorescent Microscope equipped with dual- and triple-color filters. A stained slide with the perivascular areas of 
interest was marked and used for assessing FISH signal patterns. The MDM2 amplified cells exhibited a very high 
number of red signals relative to the number of centromere control signals (CEP 12). As well as being in greater 
number, the amplified MDM2 signals were usually smaller and tightly clustered. Representative images of the 




3.1 Perivascular smooth muscle proliferation in well-differentiated liposarcoma / atypical lipomatous tumor 
(WDLPS / ALT) 
Seven cases of WDLPS / ALT with perivascular areas with the appearance of smooth muscle were identified in our 
retrospective examination of case files (Table 1). Most cases arose in either the retroperitoneum (n=3) or the lower 




 decades of life. Tumors ranged in size from 8.5 - 41 


















recurrences (28.5% of cases). Karyotype studies obtained in one case, showed supernumerary ring chromosomes, 
characteristic of WDLPS / ALT. All cases (100%, 7 of 7) demonstrated amplification of MDM2 by FISH, which 
was confirmed by MDM2 immunohistochemistry (100%, 7 of 7). 
 
The histologic appearance of the seven cases of WDLPS / ALT was first examined (Fig. 1). Tumors showed a 
variable lipomatous to sclerotic background. Perivascular areas with the appearance of smooth muscle were most 
commonly in a multifocal distribution, often clustered around groups of adjacent blood vessels (black arrowheads, 
Fig. 1). Enlarged, hyperchromatic and atypical stromal cells characteristic of liposarcoma were found within these 
perivascular areas (red arrowheads, Fig. 1). These were seen both intimately associated with the endothelium and 
also at a distance from the vessel wall (compare Fig. 1F to 1E). One case showed patchy heterologous bone 
formation (not shown).  
 
3.2 Pericyte marker expression in liposarcoma / atypical lipomatous tumor (WDLPS / ALT) 
Next, pericyte marker expression was evaluated by immunohistochemical stainings. First, perivascular areas were 
examined (Fig. 2, three representative areas in different tumors shown). In each instance, atypical stromal cells were 
seen within a perivascular location. Interestingly, these atypical stromal cells were found to be frequently positive 
for the majority of pericyte antigens (Fig. 2D-L, black arrowheads). This included consistent immunoreactivity for 
αSMA, CD146, and RGS5. Of note, PDGFRβ showed minimal staining in most cases (not shown).  
 
Next, areas within the tumor substance and apart from prominent vasculature were examined (Fig. 3). For the most 
part, pericyte antigens were not commonly seen among lipoblasts or enlarged stromal cells within WDLPS / ALT 
apart from the perivascular areas. However, on detailed examination, rare to scattered atypical stromal cells were 
seen with pan-positivity for pericyte markers (αSMA, CD146, RGS5, and PDGFRβ shown, black arrowheads). 
 
3.3 Confirmation of tumor cell origin among perivascular cells  
Nuclear enlargement and hyperchromasia among perivascular cells has previously led to the assumption that these 
were of tumor cell origin 
23


















liposarcomatous origin (MDM2 gene amplification and MDM2 expression by IHC) were assayed (Fig. 4). First, 
dual immunohistochemistry was performed for CD31 (highlighting endothelium red) and CD146 (highlighting 
perivascular cells in brown) (Fig. 4A,B). As expected CD31 immunostaining was restricted to the endothelium, 
while CD146 highlighted both perivascular and endothelial cells. Next, MDM2 amplification within perivascular 
cells was assayed by fluorescence in situ hybridization (Fig. 4C,D). A marked increase in MDM2 signals (red) was 
observed among perivascular tumor cells (vascular lumen highlighted with dashed white lines). These findings were 
confirmed with MDM2 immunohistochemical staining, demonstrating atypical perivascular cells with nuclear 
MDM2 immunoreactivity (Fig. 4E,F).  In aggregate, these studies confirm the tumor cell origin of perivascular cells 
with pericyte antigen expression in WDLPS / ALT. 
 
4. Discussion  
In summary, pericyte antigen expression is present among WDLPS / ALT tumor cells and is found 
predominantly in a perivascular distribution. Scattered single atypical stromal cells unassociated with vascular 
smooth muscle proliferation also showed pericyte antigen expression, albeit less frequently. The presence of 
multiple pericyte antigens among these vasculature-associated atypical stromal cells has strong parallels to pericytic 
mimicry, a phenomenon best described in malignant melanoma 
11-13, 27
. Pericytic mimicry has also been termed 
extravascular migratory metastasis (EVMM) or angiotropism. In general, angiotropic tumor cells are defined 
histologically as tumor cells closely associated with the endothelium of vascular channels in a pericytic location, and 
do not show intravasation into the blood vessel. While in melanoma, pericytic mimicry is generally described at the 
advancing front of the tumor, in WDLPS / ALT this phenomenon was observed in a multicentric fashion in 
association with the vasculature. 
Pericytic mimicry has been shown to be an independent poor prognostic marker in melanoma 
13
.  
Specifically, analysis of 52 patients with malignant melanoma showed a significant association between 
angiotropism and development of metastasis, with other prognostic features such as tumor thickness being identical. 
Although somewhat limited in number, our cases followed a typical disease course for WDLPS / ALT, characterized 
by local recurrence in 2/7 cases (28.5%). Of note, Gronchi et al. recently found that myogenic differentiation was 
associated with a poor prognosis in retroperitoneal liposarcoma 
28


















differentiated and dedifferentiated tumors, and included both markers of smooth and skeletal muscle differentiation. 
Thus, we consider this ’myogenic differentiation’ wholly distinct from pericytic mimicry. 
In our previous reports, we examined pericyte antigen expression among soft tissue tumors with a 
perivascular growth pattern 
29, 30
. These included glomus tumor, myopericytoma, and angioleiomyoma. Results 
showed that among all tumors a consistent expression pattern of pericyte markers was observed in relation to their 
perivascular pattern of growth, including diffuse immunoreactivity for αSMA, CD146, and PDGFRβ. Later studies 
found that angiomyolipoma and related PEComa family tumors showed relatively consistent, although patchy, 
pericytic marker expression 
30
. These expression patterns are distinct from the predominantly perivascular 
distribution of pericyte antigens in WDLPS / ALT. 
Unfortunately, no known pericytic markers are absolutely specific. For example, RGS5 expression has 




, and hepatocellular carcinomas 
33
, as well as 
various lymphomas 
33
. Likewise, CD146 expression can be found in mucoepidermoid carcinoma, gestational 
trophoblastic tumors, angiosarcoma, and Kaposi’s sarcoma, among other tumor types 
34
. However, based on the 
available literature and the present study, co-expression of multiple pericyte markers (including αSMA, CD146, 
PDGFRβ, and RGS5) is quite specific for pericytic differentiation. Other possible pericyte markers have yet to be 
investigated in soft tissue tumors, including Ang-1, Ang-2 
35
, and Nestin 
36, 37
. 
 In summary, pericyte antigen expression is present among WDLPS / ALT tumor cells and is found 
predominantly in a perivascular distribution. This phenomenon parallels pericyte mimicry, found in melanoma and 
other malignant neoplasms. The extent to which pericytic mimicry has prognostic significance in liposarcoma is as 
yet unknown. 
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Recurrence Time to 
recurrence (mo) 
1 ALT M 65 Thigh 25 No - 
2 LPS, WD M 64 Retroperitoneum 24 No - 
3 LPS, WD F 54 Retroperitoneum 25 Yes 93 
4 ALT F 43 Back 8.5 No - 
5 LPS, WD M 58 Retroperitoneum 11 Yes 20 
6 ALT F 53 Calf 20 No - 
7 ALT M 63 Thigh 41 No - 





















Fig. 1 Appearance of liposarcoma / atypical lipomatous tumor. (A-F) Histological appearance of well-
differentiated liposarcoma / atypical lipomatous tumor, by H&E staining. Areas of variably prominent perivascular 
smooth muscle differentiation were imaged, including atypical stromal cells in proximity to these areas. Red 
arrowheads indicate atypical enlarged stromal cells, while black arrowheads indicate areas of perivascular smooth 
muscle differentiation. Black scale bar: 100 μm. White scale bar: 500 μm.  
 
Fig. 2 Pericytic markers in liposarcoma / atypical lipomatous tumor. (A-C) H&E appearance. (D-F) α Smooth 
Muscle Actin (αSMA) immunohistochemical staining. (G-I) RGS5 immunohistochemical staining. (J-L) CD146 
immunohistochemical staining.  Black arrowheads indicate atypical enlarged stromal cells with positive staining. 
Black scale bar: 100 μm.  
 
Fig. 3 Pericytic markers in liposarcoma / atypical lipomatous tumor. (A,B) H&E appearance. (C,D) α Smooth 
Muscle Actin (αSMA) immunohistochemical staining. (E,F) RGS5 immunohistochemical staining. (G,H) CD146 
immunohistochemical staining. (I,J) PDGFRβ immunohistochemical staining.  Black arrowheads indicate atypical 
enlarged stromal cells with positive staining. Black scale bar: 100 μm.  
 
Fig. 4 Tumor cell origin of perivascular cells in liposarcoma / atypical lipomatous tumor. (A,B) Dual 
immunohistochemical staining for CD31 (endothelial marker, appearing red) and CD146 (pericyte marker, 
appearing brown). Please note that CD146 is known to also highlight endothelial cells. (C,D) MDM2 amplification 
by Fluorescence In Situ Hybridization. MDM2 appears red, CEP 12 appears green, and DAPI nuclear counter stain 
appears blue. White dashed lines highlight vascular lumen. (E,F) Nuclear MDM2 immunohistochemical staining. 

































































































 Pericyte mimicry has been studied in melanocytic but not mesenchymal tumors 
 
 Liposarcoma shows aberrant pericyte markers in a perivascular fashion  
 
 Pericyte mimicry is present in cells of liposarcoma rather than endothelial origin 
